Ferritins as natural and artificial nanozymes for theranostics.


Journal

Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395

Informations de publication

Date de publication:
2020
Historique:
received: 31 08 2019
accepted: 23 09 2019
entrez: 7 1 2020
pubmed: 7 1 2020
medline: 22 4 2021
Statut: epublish

Résumé

Nanozymes are a class of nanomaterials with intrinsic enzyme-like characteristics which overcome the limitations of natural enzymes such as high cost, low stability and difficulty to large scale preparation. Nanozymes combine the advantages of chemical catalysts and natural enzymes together, and have exhibited great potential in biomedical applications. However, the size controllable synthesis and targeting modifications of nanozymes are still challenging. Here, we introduce ferritin nanozymes to solve these problems. Ferritins are natural nanozymes which exhibit intrinsic enzyme-like activities (

Identifiants

pubmed: 31903145
doi: 10.7150/thno.39827
pii: thnov10p0687
pmc: PMC6929972
doi:

Substances chimiques

Enzymes 0
Ferritins 9007-73-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

687-706

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Chem Rev. 2015 Jan 14;115(1):295-326
pubmed: 25418839
Theranostics. 2019 Apr 12;9(8):2167-2182
pubmed: 31149036
J Am Chem Soc. 2008 Dec 10;130(49):16527-9
pubmed: 19554690
J Toxicol Environ Health A. 2012;75(11):603-23
pubmed: 22712847
Biomacromolecules. 2017 Oct 9;18(10):3318-3330
pubmed: 28886247
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3505-10
pubmed: 20133674
Nano Lett. 2010 Jan;10(1):219-23
pubmed: 20017497
Nat Commun. 2018 Apr 12;9(1):1440
pubmed: 29650959
Sci China Life Sci. 2016 Apr;59(4):400-2
pubmed: 27002958
Nano Lett. 2005 May;5(5):991-3
pubmed: 15884908
Biosens Bioelectron. 2015 Feb 15;64:165-70
pubmed: 25218100
Protein Cell. 2017 Nov;8(11):788-790
pubmed: 28993977
Biomaterials. 2016 Aug;98:143-51
pubmed: 27187278
Biochem J. 1973 Jun;133(2):301-9
pubmed: 4737426
J Biol Chem. 1988 Dec 5;263(34):18086-92
pubmed: 3192527
J Biol Chem. 1992 Jul 15;267(20):14077-83
pubmed: 1629207
Sci Rep. 2019 Aug 8;9(1):11499
pubmed: 31395911
J Control Release. 2014 Dec 28;196:184-96
pubmed: 25312541
Arch Toxicol. 2014 Oct;88(10):1787-802
pubmed: 25119494
Dalton Trans. 2018 Aug 14;47(32):10837-10841
pubmed: 30019062
Small. 2012 Oct 8;8(19):2948-53
pubmed: 22778042
J Inorg Biochem. 1995 Apr;58(1):59-68
pubmed: 7738539
Nanomedicine. 2013 Feb;9(2):185-93
pubmed: 22772048
Am J Physiol Cell Physiol. 2007 Aug;293(2):C641-9
pubmed: 17459943
J Struct Biol. 1999 Jun 30;126(3):182-94
pubmed: 10441528
Annu Rev Biochem. 1987;56:289-315
pubmed: 3304136
Adv Healthc Mater. 2015 Dec 30;4(18):2816-21
pubmed: 26592186
Inorg Chem. 2008 Apr 7;47(7):2237-9
pubmed: 18307300
J Nanosci Nanotechnol. 2013 Jan;13(1):60-7
pubmed: 23646698
Nanotechnology. 2017 Jan 27;28(4):045704
pubmed: 27981952
J Am Chem Soc. 2012 Sep 19;134(37):15418-29
pubmed: 22967436
Angew Chem Int Ed Engl. 2004 May 3;43(19):2527-30
pubmed: 15127443
J Mol Biol. 1991 Oct 20;221(4):1443-52
pubmed: 1942061
Theranostics. 2017 Jul 22;7(13):3207-3227
pubmed: 28900505
Nat Nanotechnol. 2007 Sep;2(9):577-83
pubmed: 18654371
Biochem J. 1997 Mar 1;322 ( Pt 2):461-8
pubmed: 9065764
Biochim Biophys Acta. 1996 Jul 31;1275(3):161-203
pubmed: 8695634
Chem Commun (Camb). 2012 Mar 28;48(26):3155-7
pubmed: 22129765
Glia. 2018 Jul;66(7):1317-1330
pubmed: 29457657
Acta Crystallogr D Biol Crystallogr. 2015 Sep;71(Pt 9):1909-20
pubmed: 26327381
ACS Nano. 2018 May 22;12(5):4105-4115
pubmed: 29608290
Chem Soc Rev. 2019 Feb 18;48(4):1004-1076
pubmed: 30534770
Biochemistry. 1998 Jul 7;37(27):9743-50
pubmed: 9657687
ACS Appl Mater Interfaces. 2019 Mar 13;11(10):9747-9755
pubmed: 30777743
Chem Commun (Camb). 2012 Jun 11;48(46):5745-7
pubmed: 22552755
PLoS One. 2014 Sep 26;9(9):e106974
pubmed: 25259650
Oncotarget. 2016 Oct 11;7(41):66713-66727
pubmed: 27579532
PLoS One. 2011;6(8):e23800
pubmed: 21886823
Expert Opin Drug Deliv. 2017 Jul;14(7):825-840
pubmed: 27690258
PLoS One. 2017 Aug 24;12(8):e0182954
pubmed: 28837569
Chem Soc Rev. 2019 Jul 15;48(14):3683-3704
pubmed: 31119258
J Colloid Interface Sci. 2019 Mar 1;537:20-27
pubmed: 30415098
J Control Release. 2019 Oct;311-312:288-300
pubmed: 31494184
Mater Sci Eng C Mater Biol Appl. 2019 Jan 1;94:831-840
pubmed: 30423769
ACS Nano. 2012 May 22;6(5):4001-12
pubmed: 22533614
Biochemistry (Mosc). 1998 Oct;63(10):1191-9
pubmed: 9864454
Inorg Chem. 2005 May 2;44(9):3203-9
pubmed: 15847428
Biotechnol Bioeng. 2003 Oct 20;84(2):187-94
pubmed: 12966575
J Am Chem Soc. 2006 Dec 27;128(51):16626-33
pubmed: 17177411
Small. 2010 Jul 19;6(14):1483-7
pubmed: 20623737
Biochem J. 1992 Dec 1;288 ( Pt 2):591-6
pubmed: 1463463
Nat Nanotechnol. 2012 Jun 17;7(7):459-64
pubmed: 22706697
Bioorg Khim. 1999 Jul;25(7):528-36
pubmed: 10563206
J Am Chem Soc. 2018 Sep 12;140(36):11302-11307
pubmed: 30118222
J Exp Med. 2005 Oct 3;202(7):955-65
pubmed: 16203866
Chem Commun (Camb). 2014 Jul 28;50(59):8021-3
pubmed: 24918108
Acc Chem Res. 2019 Aug 20;52(8):2190-2200
pubmed: 31276379
Small. 2011 Jun 6;7(11):1538-41
pubmed: 21538872
Biomaterials. 2011 Feb;32(6):1611-8
pubmed: 21112084
J Neurochem. 2008 Dec;107(6):1495-505
pubmed: 19014383
Biochemistry. 2017 Aug 1;56(30):3900-3912
pubmed: 28636371
Nanotechnology. 2017 May 12;28(19):195601
pubmed: 28332483
ACS Nano. 2013 Aug 27;7(8):6988-96
pubmed: 23829542
Science. 1992 Jul 24;257(5069):522-3
pubmed: 1636086
Biosens Bioelectron. 2015 Dec 15;74:134-41
pubmed: 26134291
Dev Cell. 2009 Jan;16(1):35-46
pubmed: 19154717
Chem Commun (Camb). 2007 Sep 7;(33):3453-5
pubmed: 17700879
FEBS Lett. 1989 Aug 28;254(1-2):207-10
pubmed: 2776883
Anal Chem. 2011 Nov 15;83(22):8611-6
pubmed: 21910434
Pharmacol Res. 2016 May;107:57-65
pubmed: 26968122
Nanotechnology. 2012 Jan 27;23(3):035102
pubmed: 22173232
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14900-5
pubmed: 25267615
Water Res. 2015 Jun 1;76:181-6
pubmed: 25817554
Biochemistry (Mosc). 1997 Dec;62(12):1415-23
pubmed: 9481874
Inorg Chem. 2005 Sep 5;44(18):6393-400
pubmed: 16124819
Philos Trans R Soc Lond B Biol Sci. 1984 Feb 13;304(1121):551-65
pubmed: 6142491
Chem Commun (Camb). 2009 Aug 28;(32):4871-3
pubmed: 19652809

Auteurs

Bing Jiang (B)

Joint Laboratory of Nanozymes in Zhengzhou University, Academy of Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, China.

Long Fang (L)

CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China.
Savaid Medical School, University of Chinese Academy of Sciences, Beijing 100049, China.

Kongming Wu (K)

Joint Laboratory of Nanozymes in Zhengzhou University, Academy of Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, China.
Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

Xiyun Yan (X)

Joint Laboratory of Nanozymes in Zhengzhou University, Academy of Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, China.
CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China.

Kelong Fan (K)

Joint Laboratory of Nanozymes in Zhengzhou University, Academy of Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, China.
CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH